Although originally designed for glycemic control in T2D, GLP-1 RAs and their advanced multi-agonist derivatives are now being applied in cardiometabolic and even neurodegenerative conditions
Deficiencies can manifest as fatigue, brain fog, increased hunger, and slower weight loss
However, a promising medication called Semaglutide has recently emerged as a game-changer in the field of weight loss
Your doctor will decide which one is best for you based on your current glucose levels and needs
Allelic Variant in the Glucagon-like Peptide 1 Receptor Gene Associated with Greater Effect of Liraglutide and Exenatide on Gastric Emptying: A Pilot Pharmacogenetics Study. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society, vol
If concerning patterns emerge, the FDA may take actions such as requiring changes to a drugs labeling, issuing safety communications, or withdrawing approval in severe cases